Press Releases

New research indicates attention on laboratory modernization. As the Association for Diagnostics and Laboratory Medicine 2026 Annual Scientific Meeting and Clinical Lab Expo kicks off, Siemens Healthineers will unveil innovations designed to optimize strategic impact.

• Value Partnership will drive technology upgrades and standardization across diagnostic imaging and radiation oncology, promote workforce development
• Collaboration will empower healthcare innovation through scalable AI uses in radiology, personalized medicine, and workflow automation

• Capillary testing is a patient-friendly option and ideal for difficult veins
• Capillary capability helps scale core labs’ testing offerings easily using existing infrastructure
• The CE-marked capillary claims are validated to run on the Atellica analyzers

• The study data support the safety and effectiveness of proton Flash therapy at ultra-high dose rates in bone metastases of the thorax

• These results represent a significant step toward bringing proton Flash technology into clinical practice as an effective option with fewer side effects

Most patients need hematology tests, and fast results help inform timely care decisions

Laboratory workflows affect how quickly clinicians receive time-sensitive test results 

The hematology analyzer simplifies complex testing for consistency across varying staff expertise

• Improved image reconstruction supports diagnosis even in dense breast tissue
• Contrast-enhanced biopsy boosts diagnostic confidence 
• Features build on system’s ability to create high-resolution 3D mammograms in under 5 seconds

• The average hospital experiences more than 2,300 cyberattacks per week¹, costing the industry billions annually.

• The SHIELD project aims to develop artificial intelligence (AI) cyber-threat solutions to optimize security updates for hospital equipment.

• Optiq AI addresses demand for precision and high image quality in image-guided therapy. 
• Deep-learning-based noise reduction improves quality of live images. 
• New portfolio addresses wide range of clinical uses, operational needs, and financial considerations.

• The Atellica TSTII Testosterone assay is the only immunoassay with CDC HoST-TT Certification. 
• Certification reaffirms assay results are aligned with specialized mass spectrometry testing method. 
• The immunoassay test is a broadly available, economical option for patients and laboratories.

Collaborative agreement focuses on operational efficiencies, bringing new technology to the growing health system and Onvida Health’s commitment to building a healthier tomorrow

• Research assays help generate evidence about whether biomarkers can advance disease management
• Novel RUO tests can help scientists understand neurological function and disease progression
• Collaborative research is underway to translate scientific discovery into actionable evidence

• Animal Neurology Center in St. Louis installs helium-free 1.5T MR scanner for veterinary use
• Scanner also covers entire range of MR applications for general radiology